Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Nurix Therapeutics, Inc. - Common stock
(NQ:
NRIX
)
25.06
+0.37 (+1.50%)
Streaming Delayed Price
Updated: 1:02 PM EDT, Aug 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Nurix Therapeutics, Inc. - Common stock
< Previous
1
2
3
4
5
Next >
What's going on in today's after hours session
↗
July 09, 2025
Let's have a look at what is happening on the US markets after the closing bell on Wednesday. Below you can find the top gainers and losers in today's after hours session.
Via
Chartmill
Sanofi Expands Rare Immunology Portfolio With Blueprint Buyout
↗
June 02, 2025
Sanofi will acquire Blueprint Medicines for up to $9.5 billion, gaining Ayvakit and a promising immunology pipeline, including BLU-808 and elenestinib.
Via
Benzinga
Breaking Down Nurix Therapeutics: 7 Analysts Share Their Views
↗
April 29, 2025
Via
Benzinga
Cathie Wood Buys More NVIDIA And AMD Stock As Chinese Tech Giants Stockpile Chips Amid Looming US Export Curbs
↗
April 23, 2025
On Wednesday, April 23, 2025, Cathie Wood of Ark Invest purchased more stock of AMD and Nvidia amid looming US chip curbs against China.
Via
Benzinga
8 Analysts Have This To Say About Nurix Therapeutics
↗
January 29, 2025
Via
Benzinga
Decoding 9 Analyst Evaluations For Nurix Therapeutics
↗
December 06, 2024
Via
Benzinga
The Analyst Verdict: Nurix Therapeutics In The Eyes Of 10 Experts
↗
November 06, 2024
Via
Benzinga
Expert Outlook: Nurix Therapeutics Through The Eyes Of 9 Analysts
↗
April 02, 2025
Via
Benzinga
Beyond The Numbers: 8 Analysts Discuss Nurix Therapeutics Stock
↗
March 17, 2025
Via
Benzinga
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500
↗
October 31, 2024
The Ark Innovation and Ark Genomic ETFs turn ten years old. A look at the annual returns and current top holdings.
Via
Benzinga
Topics
ETFs
Stocks
Wells Fargo To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Monday
↗
October 14, 2024
Via
Benzinga
Unveiling 6 Analyst Insights On Nurix Therapeutics
↗
October 11, 2024
Via
Benzinga
Analyst Ratings For Nurix Therapeutics
↗
September 04, 2024
Via
Benzinga
Forecasting The Future: 13 Analyst Projections For Nurix Therapeutics
↗
July 31, 2024
Via
Benzinga
Boeing, Nurix Therapeutics And 3 Stocks To Watch Heading Into Monday
↗
October 14, 2024
Via
Benzinga
This Amazon Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
↗
October 11, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
October 10, 2024
Via
Benzinga
Nvidia’s Earnings Loom In The Summer Stock Snooze-Fest
↗
August 27, 2024
To the casual observer, stocks look to be drifting around on a Lazy River ride, but the truth is, they’re consolidating their recent gains. This is actually bullish price action.
Via
Talk Markets
Analyst Scoreboard: 12 Ratings For Nurix Therapeutics
↗
July 15, 2024
Via
Benzinga
Expert Outlook: Nurix Therapeutics Through The Eyes Of 14 Analysts
↗
June 27, 2024
Via
Benzinga
Peeling Back The Layers: Exploring Nurix Therapeutics Through Analyst Insights
↗
June 05, 2024
Via
Benzinga
Key Takeaways From Nurix Therapeutics Analyst Ratings
↗
May 14, 2024
Via
Benzinga
TJX To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Wednesday
↗
August 14, 2024
Via
Benzinga
Here Is What You Missed On Wall Street On Friday
↗
July 14, 2024
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.
Via
Talk Markets
Stock Market Weekly Review: Nvidia, AI Chip Plays Hit Resistance
↗
June 21, 2024
The Nasdaq and S&P 500 backed off highs. The Dow regained a key level.
Via
Investor's Business Daily
Topics
Artificial Intelligence
Stocks
Nvidia To Rally Around 53%? Here Are 10 Top Analyst Forecasts For Tuesday
↗
June 18, 2024
Via
Benzinga
What's Going On With Small-Cap Cancer Focused Nurix Therapeutics On Monday?
↗
June 17, 2024
Nurix Therapeutics presented updated clinical data for NX-5948, an orally bioavailable BTK degrader, at the EHA Congress. NX-5948 showed promising safety and efficacy in Phase 1a/b trials for...
Via
Benzinga
Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
↗
June 17, 2024
Via
Benzinga
Biotech Stock Nurix Therapeutics Jumps On Positive Leukemia Treatment Trial
↗
June 17, 2024
San Francisco-based Nurix Therapeutics reported robust results in an ongoing treatment against a stubborn form of leukemia.
Via
Investor's Business Daily
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
↗
June 17, 2024
We have all of the biggest pre-market stock movers that investors are going to want to keep an eye on for Monday morning!
Via
InvestorPlace
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
